Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00695422 · ClinicalTrials.gov registry record

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

A clinical trial, sponsored by AIDS Malignancy Consortium.

Completed
Registry status
47
Enrollment target

NCT00695422: Completed study, sponsored by AIDS Malignancy Consortium.

NCT00695422 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00695422 has completed, sponsored by AIDS Malignancy Consortium.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical trial is studying ways to detect anal and genital human papillomavirus infection and squamous intraepithelial lesions in HIV-positive patients enrolled in an AIDS cancer clinical trial.

Interventions

  • OTHER cytology specimen collection procedure
  • GENETIC polymerase chain reaction
  • PROCEDURE colposcopic biopsy
  • OTHER histological technique

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2008-05-14
Est. Completion 2017-04-19
AIDS Malignancy Consortium

45 total trials

What the finished NCT00695422 record still lists

NCT00695422 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.

The record links to 0 conditions, and to 4 interventions - of which cytology specimen collection procedure is the first listed.

NCT00695422 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00695422 about?

NCT00695422 is a clinical study titled "Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials". RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical t...

What is the current status of trial NCT00695422?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2008-05-14. Estimated completion is 2017-04-19.

What interventions are being tested in trial NCT00695422?

The interventions under investigation include: cytology specimen collection procedure (OTHER), polymerase chain reaction (GENETIC), colposcopic biopsy (PROCEDURE), histological technique (OTHER).

Who is sponsoring clinical trial NCT00695422?

This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00695422, the US trial registry maintained by the National Library of Medicine. NCT00695422 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.